CRISPR THERAPEUTICCC

CRISPR THERAPEUTIC

40,486CHFC
−1,032−2,49%
Kapanışta 27 Şub 14:00 GMT
CHF
İşlem yok
Süper-grafiklerde görün
Geri

İşletme giderleri (COGS hariç)'in CRISPR THERAPEUTIC

Yıllık veri
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
‪‪−520,00 M‬‬
‪‪−390,00 M‬‬
‪‪−260,00 M‬‬
‪‪−130,00 M‬‬
‪0,00‬
Dönem
Değer
Değişim
Değişim %
TTM
‪‪−339,95 M‬‬
+‪‪56,31 K‬‬
+‪0,02‬%
2024
‪‪−340,00 M‬‬
+‪‪33,53 M‬‬
+‪8,98‬%
2023
‪‪−373,53 M‬‬
+‪‪125,76 M‬‬
+‪25,19‬%
2022
‪‪−499,29 M‬‬
‪‪−21,71 M‬‬
‪−4,55‬%
2021
‪‪−477,59 M‬‬
‪‪−171,77 M‬‬
‪−56,17‬%
2020
‪‪−305,82 M‬‬
‪‪−75,23 M‬‬
‪−32,63‬%
2019
2018
2017
2016
2015
3 ay veri
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−120,00 M‬‬
‪‪−90,00 M‬‬
‪‪−60,00 M‬‬
‪‪−30,00 M‬‬
‪0,00‬
Dönem
Değer
Değişim
Değişim %
Q4 '24
‪‪−86,68 M‬‬
‪‪−6,36 M‬‬
‪−7,92‬%
Q3 '24
‪‪−80,32 M‬‬
+‪‪4,91 M‬‬
+‪5,76‬%
Q2 '24
‪‪−85,23 M‬‬
‪‪−4,68 M‬‬
‪−5,81‬%
Q1 '24
‪‪−80,55 M‬‬
+‪‪9,30 M‬‬
+‪10,35‬%
Q4 '23
‪‪−89,85 M‬‬
+‪‪5,42 M‬‬
+‪5,69‬%
Q3 '23
‪‪−95,27 M‬‬
+‪‪8,27 M‬‬
+‪7,99‬%
Q2 '23
‪‪−103,54 M‬‬
+‪‪3,79 M‬‬
+‪3,53‬%
Q1 '23
‪‪−107,34 M‬‬
+‪‪2,59 M‬‬
+‪2,36‬%
Q4 '22
Q3 '22
Q2 '22
Q1 '22
Q4 '21
Q3 '21
Q2 '21
Q1 '21
Q4 '20
Q3 '20
Q2 '20
Q1 '20
Q4 '19
Q3 '19
Q2 '19
Q1 '19
Q4 '18
Q3 '18
Q2 '18
Q1 '18
Q4 '17
Q3 '17
Q2 '17